Nektar Therapeutics Inc. (NKTR)
NASDAQ · Healthcare
Nektar Therapeutics Inc. Income Statement 2009–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenue | 55.2M | 98.4M | 90.1M | 92.1M | 101.9M | 152.9M | 114.6M | 1.19B | 307.7M | 165.4M | 230.8M | 200.7M | 148.9M | 81.2M | 71.5M | 159.0M | 71.9M |
| Gross Profit | 55.2M | 67.7M | 56.4M | 70.4M | 77.0M | 133.4M | 93.2M | 1.17B | 277.2M | 135.2M | 196.7M | 172.2M | 110.4M | 50.8M | 49.6M | 133.4M | 41.0M |
| Profitability | |||||||||||||||||
| Operating Income | -140.1M | -105.2M | -263.7M | -376.2M | -446.1M | -425.1M | -440.0M | 687.9M | -59.6M | -112.9M | -29.4M | -16.5M | -120.1M | -141.2M | -123.9M | -28.3M | -95.1M |
| EBITDA | -139.1M | -101.1M | -256.7M | -364.0M | -433.1M | -412.6M | -429.0M | 696.7M | -47.0M | -99.7M | -18.0M | -3.6M | -105.9M | -126.7M | -109.0M | -11.7M | -80.3M |
| Net Income | -164.1M | -119.0M | -276.1M | -368.2M | -523.8M | -444.4M | -440.7M | 681.3M | -96.7M | -153.5M | -81.2M | -53.9M | -162.0M | -171.9M | -134.0M | -37.9M | -102.5M |
| Per Share Data | |||||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 17M | 14M | 190M | 187M | 183M | 179M | 175M | 180M | 156M | 140M | 135M | 131M | 116M | 115M | 114M | 95M | — |
Nektar Therapeutics Inc. Income Statement — FAQ
Nektar Therapeutics Inc. (NKTR) income statement over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NKTR's income statement history?
The chart and table above show Nektar Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.